CA1073358A - Sustained release formulations - Google Patents

Sustained release formulations

Info

Publication number
CA1073358A
CA1073358A CA248,018A CA248018A CA1073358A CA 1073358 A CA1073358 A CA 1073358A CA 248018 A CA248018 A CA 248018A CA 1073358 A CA1073358 A CA 1073358A
Authority
CA
Canada
Prior art keywords
weight
sustained release
tablet
formulation
gastric fluid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA248,018A
Other languages
English (en)
French (fr)
Inventor
Prabhakar R. Sheth
Jacques L. Tossounian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Application granted granted Critical
Publication of CA1073358A publication Critical patent/CA1073358A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA248,018A 1975-03-17 1976-03-16 Sustained release formulations Expired CA1073358A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (1)

Publication Number Publication Date
CA1073358A true CA1073358A (en) 1980-03-11

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
CA248,018A Expired CA1073358A (en) 1975-03-17 1976-03-16 Sustained release formulations

Country Status (21)

Country Link
JP (1) JPS51115910A (de)
AR (1) AR222624A1 (de)
AT (1) AT353415B (de)
AU (1) AU505355B2 (de)
CA (1) CA1073358A (de)
CH (1) CH630257A5 (de)
DD (1) DD124102A5 (de)
DE (1) DE2611041A1 (de)
DK (1) DK148344C (de)
ES (1) ES446075A1 (de)
FR (1) FR2304354A1 (de)
GB (1) GB1546448A (de)
GR (1) GR60341B (de)
IE (1) IE43083B1 (de)
LU (1) LU74558A1 (de)
MC (1) MC1101A1 (de)
NL (1) NL190313C (de)
NZ (1) NZ180321A (de)
PH (1) PH14927A (de)
PT (1) PT64907B (de)
SE (1) SE433804B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982000094A1 (en) * 1980-07-02 1982-01-21 Laby R Controlled release compositions for administration of therapeutic agents to ruminants

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
NL194822C (nl) * 1985-10-01 2003-04-03 Novartis Ag Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
WO1992017166A1 (en) * 1991-04-08 1992-10-15 Nippon Shinyaku Co., Ltd. Capsule
ES2124303T3 (es) * 1992-03-25 1999-02-01 Depomed Inc Formas de dosificacion de farmacos orales de liberacion retardada a base de hidroxietilcelulosa.
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
WO1995011667A1 (en) * 1993-10-29 1995-05-04 R.P. Scherer Corporation Gelatin capsule fill able to foam
WO1995011668A1 (en) * 1993-10-29 1995-05-04 Reckitt & Colman Products Limited Gelatin capsule fill able to foam
AU707454B2 (en) * 1994-05-13 1999-07-08 Smithkline Beecham Corporation Method and composition for increasing calcium uptake
MX9704043A (es) * 1994-12-01 1998-02-28 Cibus Pharmaceuticals Inc Surtido de farmaco de liberacion sostenida empleando una goma de hidrocoloide en polvo obtenible a partir de plantas superiores.
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
EP1245227A1 (de) 2001-03-31 2002-10-02 Jagotec Ag Pharmazeutische, im Magen aufschwimmende Tablette für die programmierte Freisetzung des Wirkstoffes und Verfahren zur Herstellung des in der Tablette enthaltenen schwimmfähigen Materials
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (de) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982000094A1 (en) * 1980-07-02 1982-01-21 Laby R Controlled release compositions for administration of therapeutic agents to ruminants
US4671789A (en) * 1980-07-02 1987-06-09 Commonwealth Scientific And Industrial Research Organization Controlled release compositions for administration of therapeutic agents to ruminants

Also Published As

Publication number Publication date
DD124102A5 (de) 1977-02-02
IE43083B1 (en) 1980-12-17
PT64907A (fr) 1976-04-01
PH14927A (en) 1982-01-29
SE433804B (sv) 1984-06-18
NL190313C (nl) 1994-01-17
DE2611041C2 (de) 1988-06-09
NL7602776A (nl) 1976-09-21
ATA192276A (de) 1979-04-15
IE43083L (en) 1976-09-17
JPS51115910A (en) 1976-10-13
DE2611041A1 (de) 1976-10-14
FR2304354B1 (de) 1979-04-27
DK113676A (da) 1976-09-18
MC1101A1 (fr) 1977-02-04
DK148344C (da) 1985-11-04
JPS638084B2 (de) 1988-02-19
AU505355B2 (en) 1979-11-15
AT353415B (de) 1979-11-12
NZ180321A (en) 1978-06-20
NL190313B (nl) 1993-08-16
DK148344B (da) 1985-06-17
ES446075A1 (es) 1977-09-16
AU1204976A (en) 1977-09-22
FR2304354A1 (fr) 1976-10-15
PT64907B (fr) 1978-03-24
CH630257A5 (en) 1982-06-15
GR60341B (en) 1978-05-17
SE7603325L (sv) 1976-09-18
GB1546448A (en) 1979-05-23
LU74558A1 (de) 1977-09-27
AR222624A1 (es) 1981-06-15

Similar Documents

Publication Publication Date Title
CA1073358A (en) Sustained release formulations
US4140755A (en) Sustained release tablet formulations
US4167558A (en) Novel sustained release tablet formulations
US4126672A (en) Sustained release pharmaceutical capsules
US4814179A (en) Floating sustained release therapeutic compositions
US5232704A (en) Sustained release, bilayer buoyant dosage form
CA1295247C (en) Sustained release capsule
Gopalakrishnan et al. Floating drug delivery systems: A Review
EP0797435B1 (de) Matrix zur gesteuerten freisetzung von arzneistoffen
US4708834A (en) Preparation of gelatin-encapsulated controlled release composition
EP0698389B1 (de) Verzögerte Freigabe Matrix für Arzneimittel
US3146169A (en) Pharmaceutical formulations and their manufacture
EP0265061B1 (de) Arzneiformulierung
US4795642A (en) Gelatin-encapsulated controlled-release composition
CA1156554A (en) Alkaline analgesic capsule
KR20040105773A (ko) 마이크로캡슐을 포함하는 변형 방출형 압축 정제
WO2005079384A2 (en) Expandable gastric retention device
US4814178A (en) Floating sustained release therapeutic compositions
GB2105590A (en) Flotable controlled release preparations
JPH0625064B2 (ja) 制御放出塩化カリウム
US5374430A (en) Pharmaceutical formulation
JP2005501097A (ja) 膨張可能な胃内滞留装置
EP0198769A2 (de) Schwimmfähige therapeutische Mittel mit verzögerter Freisetzung
Bagul et al. Stomach specific drug delivery systems: a review
EP4313014A1 (de) Verfahren zur herstellung gastroretentiver kompakter matrizen zur kontrollierten freisetzung von wirkstoffen und so erhaltene kompakte matrizen

Legal Events

Date Code Title Description
MKEX Expiry